Particle accelerator technology
4 European H2020 organizations list this as part of their work — 3 as their primary capability.
Most active in this area
- EBG MEDAUSTRON GMBH
Austrian ion beam therapy centre combining clinical cancer treatment with particle accelerator research and medical isotope science.
“HITRIplus focuses on superconducting gantry and synchrotron development; OMA addresses beam diagnostics and accelerator optimization.”
PrimarySMEAT5 projects - HEIDELBERGER IONENSTRAHL THERAPIE (HIT) BETRIEBS GESELLSCHAFT AM UNIVERSITATSKLINIKUM HEIDELBERG MIT BESCHRANKTER HAFTUNG
Heidelberg's heavy ion beam therapy center, combining clinical cancer treatment with accelerator R&D and superconducting beam delivery research.
“ARIES, I.FAST, and HITRIplus all involve accelerator R&D — from superconducting synchrotrons to general accelerator innovation for science and society.”
PrimaryDE4 projects - ELYTT ENERGY SL
Spanish SME specializing in superconducting magnet technology and accelerator science, bridging physics research infrastructure and industrial energy applications.
“I.FAST directly covers accelerator science and technology, with keywords spanning accelerator, synchrotron, and collider — placing ELYTT inside the European accelerator industry ecosystem.”
SMEES2 projects - KYMA S.P.A.
Italian technology company providing specialist expertise in particle accelerator systems, X-ray light sources, and superconducting accelerator components for European research infrastructure.
“Both H2020 projects (CompactLight and I.FAST) are directly focused on accelerator design, innovation, and infrastructure.”
PrimaryIT2 projects